Ortho Clinical Diagnostics, otu n'ime ụlọ ọrụ nyocha nyocha vitro kachasị ukwuu n'ụwa, kwupụtara mwepụta nke nnwale mgbochi COVID-19 IgG mbụ yana nnwale mgbochi COVID-19 nucleocapsid zuru oke.
Ortho bụ naanị ụlọ ọrụ dị na United States na-enye ngwakọta nke nyocha ọnụọgụ na nyocha nucleocapsid maka ụlọ nyocha.Nnwale abụọ a na-enyere ndị otu ahụike aka ịmata ihe kpatara ọgwụ mgbochi megide SARS-CoV-2 wee hazie ya na sistemụ VITROS® nke Ortho tụkwasịrị obi.
Ivan Sargo, MD, Ortho Clinical Diagnostics, onye isi ọgwụ, ihe gbasara ahụike na sayensị kwuru na "Na United States, a na-eme ọgwụ mgbochi niile iji mepụta nzaghachi mgbochi mmadụ na protein spike nke nje SARS-CoV-2.""Nnwale nyocha ọhụụ nke Ortho nke IgG, yana ule ọhụrụ nucleocapsid antibody, nwere ike ịnyekwu data iji nyere aka chọpụta ma nzaghachi mgbochi ahụ sitere na ọrịa sitere n'okike ma ọ bụ ọgwụ mgbochi protein ezubere iche."
Ortho's VITROS® Anti-SARS-CoV-2 IgG quantitative antibody test bụ nnwale mgbochi mbụ na United States iji nye ụkpụrụ ahazigoro dịka ụkpụrụ mba ụwa nke Healthtù Ahụ Ike (wa (WHO) siri dị.2 Nnwale mgbochi ọnụọgụ ọnụọgụ na-enyere aka ịhazi usoro SARS-CoV-2 serological ma na-enye ohere ntụle data otu n'ofe ụlọ nyocha.Ihe omuma a jikọtara ọnụ bụ nzọụkwụ mbụ n'ịghọta ịrị elu na ọdịda nke ọgwụ mgbochi ọrịa n'otu n'otu yana mmetụta ogologo oge nke ọrịa COVID-19 na-emetụta obodo na ọnụ ọgụgụ mmadụ dum.
Emebere ule ọnụọgụ IgG ọhụrụ nke Ortho ka ọ tụọ ọgwụ mgbochi IgG megide SARS-CoV-2 na ọbara mmadụ na plasma, yana nkọwapụta 100% na ezi uche dị mma.3
Ortho ọhụrụ VITROS® Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test bụ nnwale 4 ziri ezi nke ukwuu maka nchọpụta qualitative nke SARS-CoV-2 nucleocapsid na ndị ọrịa butere ọrịa nje SARS-CoV-2.
Chockalingam Palaniappan kwuru, "Anyị na-amụta ihe ọhụrụ mgbe niile gbasara nje SARS-CoV-2 kwa ụbọchị, Ortho na-agba mbọ ịkwado ụlọ nyocha na ngwọta dị oke mma iji nyere ha aka ịnagide ihe ịma aka ugbu a na n'ọdịnihu nke ọrịa a na-aga n'ihu," Dr. Chockalingam Palaniappan kwuru. , Chief Innovation Officer of Ortho Clinical Diagnostics.
Nnwale mgbochi ọnụọgụ ọnụọgụ nke Ortho nke COVID-19 mezuru usoro ngosi iji ihe mberede US Food and Drug Administration (FDA) na Mee 19, 2021 ma nyefee ikike iji ihe mberede (EUA) maka ule ahụ na FDA.Ya VITROS® Anti-SARS-CoV-2 ngụkọta nucleocapsid mgbochi nnwale mezuru usoro EUN na Mee 5, 2021, ma nyefee EUA.
Ị chọrọ izipu akụkọ sayensị kachasị ọhụrụ ozugbo na igbe mbata gị?Bụrụ onye otu SelectScience ugbu a n'efu >>
1. Ndị ọrịa gbanyere ọgwụ mgbochi nje anaghị arụ ọrụ ga-emepụta ọgwụ mgbochi N na mgbochi S.2. https://www.who.int/publications/m/item/WHO-BS-2020.2403 3. 100% nkọwa, 92.4% uche karịa 15 ụbọchị mgbe mmalite nke mgbaàmà 4. 99.2% nkọwa na 98.5% PPA ≥ 15 ụbọchị mgbe mmalite nke mgbaàmà
Oge nzipu: Jun-22-2021